JPS6025916A - 入浴水 - Google Patents

入浴水

Info

Publication number
JPS6025916A
JPS6025916A JP13337783A JP13337783A JPS6025916A JP S6025916 A JPS6025916 A JP S6025916A JP 13337783 A JP13337783 A JP 13337783A JP 13337783 A JP13337783 A JP 13337783A JP S6025916 A JPS6025916 A JP S6025916A
Authority
JP
Japan
Prior art keywords
lipid
sodium tungstate
diseases
bathing
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP13337783A
Other languages
English (en)
Inventor
Tadashi Kase
英行 平出
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP13337783A priority Critical patent/JPS6025916A/ja
Publication of JPS6025916A publication Critical patent/JPS6025916A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

(57)【要約】本公報は電子出願前の出願データであるた
め要約のデータは記録されません。

Description

【発明の詳細な説明】 本発明は血液中の過酸化脂質の皿が過大となることが主
因とされる疾患、例えば白内障、動脈硬化、心ＷＡ障害
、糖尿病、胃潰瘍、腸潰瘍、歯槽膿漏など患者の入浴に
用いて顕著な薬効を有する新規な入浴水に関するもので
ある。
そもそも、白内障、動脈硬化、心臓障害、糖尿病、胃潰
瘍、腸潰瘍、歯槽膿漏などの疾患患は血液中の過酸化脂
質が過大となることに起因するものであることは医学界
の定説となっており、例えば、白内障については、血液
中に増えた過酸化脂質が眼の水晶体に栄養を送る前゛房
水の中に運び込まれて水晶体を傷つけ、水晶体が濁って
視力を失うという発症の機構が解明されている。
そして、本発明の発明者はタンメステン酸ナトリューム
にこのような一過酸化脂質を還元して元の不飽和脂肪酸
に戻す作用があることを発見し、このタングステン酸ナ
ト９ニームを主たる浴剤とする温水に入浴し同タングス
テン酸ナトリュームを皮膚から吸収することによって血
液中の過酸化脂質を減少し前記の諸疾患の予防や進行の
抑制若しくは治癒を期し得ることを多数の臨床例によっ
て確認することができた。
本発明は上記の諸疾患の病理とタングステン酸ナトリュ
ームの上記の特性の発見に基いて創出されたものであっ
て、清水にタングステン酸ナトリュームを主成分とする
浴剤を溶解したことを特徴とするのでこの入浴水な加温
してこれに入浴する療法を反復するときは上記の白内障
、動脈硬化、心臓障害、糖尿病、胃潰瘍、腸潰瘍、歯槽
膿漏など治癒するに至る効果がある。
特許出願人　１）中　精之助

Claims (1)

    【特許請求の範囲】
  1. 清水（ニタングステン酸す、ト９゛ニームを主成分とす
    る浴剤を溶解したことを特徴とする入浴水。
JP13337783A 1983-07-21 1983-07-21 入浴水 Pending JPS6025916A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP13337783A JPS6025916A (ja) 1983-07-21 1983-07-21 入浴水

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13337783A JPS6025916A (ja) 1983-07-21 1983-07-21 入浴水

Publications (1)

Publication Number Publication Date
JPS6025916A true JPS6025916A (ja) 1985-02-08

Family

ID=15103310

Family Applications (1)

Application Number Title Priority Date Filing Date
JP13337783A Pending JPS6025916A (ja) 1983-07-21 1983-07-21 入浴水

Country Status (1)

Country Link
JP (1) JPS6025916A (ja)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02281775A (ja) * 1989-04-24 1990-11-19 Takashi Mori 光発振器
EP0755681A1 (en) * 1995-07-19 1997-01-29 Quimica Farmaceutica Bayer, S.A. Tungsten (VI) compositions for the oral treatment of diabetes mellitus
ES2108642A1 (es) * 1995-07-26 1997-12-16 Quimica Farm Bayer Sa Composiciones de tungsteno (vi) para el tratamiento oral de la diabetes mellitus.

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02281775A (ja) * 1989-04-24 1990-11-19 Takashi Mori 光発振器
EP0755681A1 (en) * 1995-07-19 1997-01-29 Quimica Farmaceutica Bayer, S.A. Tungsten (VI) compositions for the oral treatment of diabetes mellitus
ES2108642A1 (es) * 1995-07-26 1997-12-16 Quimica Farm Bayer Sa Composiciones de tungsteno (vi) para el tratamiento oral de la diabetes mellitus.

Similar Documents

Publication Publication Date Title
Heimbach et al. Toxic epidermal necrolysis: a step forward in treatment
POST et al. Demodex folliculorum and blepharitis
Gianotti et al. Benign cephalic histiocytosis
US4302471A (en) Method of treating cardiac and renal failures
US4626530A (en) Treatment of eye inflammation with biphenamine
ATE6645T1 (de) Dibenzoxazepin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
JPS6025916A (ja) 入浴水
CZ181193A3 (en) Pharmaceutical preparation in the form of a solution for local administration in eye, the use and preparation method thereof
JD Pulmonary changes in disseminated lupus erythematosus.
SMITH et al. Ocular and oral pemphigus: report of a case with anatomic findings in the eyeball
JPS6025928A (ja) 薬剤
JPH05117140A (ja) ビタミンｂ１含有ニンニクエキス配合石鹸
Goodhill Penicillin treatment of cavernous sinus thrombosis
Winkelman et al. Prostigmin in the Treatment of Myasthenia Gravis and Muscular Dystrophy: Results Obtained with Divided Doses
DE3631169A1 (de) Prostacyclinderivate enthaltende mittel fuer die topische anwendung
JPH05502439A (ja) 点眼薬
JPH0641409B2 (ja) 眼科用液剤
EP0477833A1 (en) Composition for therapeutic and/or cosmetic use for treatment of circulatory diseases and for aesthetic medicine treatments
Falconer The importance of optic neuritis and retinal hemorrhages in the diagnosis of chronic septic endocarditis
JPH06263647A (ja) 過酸化脂質の抑制剤
Benedict Retinitis of hypertension plus nephritis
JPS6317828A (ja) 骨形成促進剤
HUT45989A (en) Process for production of derivatives of 1,4-dihydropiridine and medical preparatives containing them as active substance
JPS6183121A (ja) 虚血性潰瘍治療剤
Broders Early treatment of thermal burns